Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 season

Influenza and other Respiratory Viruses

Volumn 8, Issue 2, 2014, Pages 151-158

  Koseki, Naoko ^a   Kaiho, Miki ^a   Kikuta, Hideaki ^b   Oba, Koji ^c   Togashi, Takehiro ^d   Ariga, Tadashi ^a   Ishiguro, Nobuhisa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Touei Hospital   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d SAPPORO CITY UNIVERSITY   (Japan)

Author keywords

Biphasic fever; Influenza; Laninamivir octanoate; Neuraminidase inhibitors; Zanamivir

Indexed keywords

BIPHASIC FEVER; INFLUENZA; LANINAMIVIR OCTANOATE; NEURAMINIDASE INHIBITORS; ZANAMIVIR;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; IMMUNOCHROMATOGRAPHY; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; ZANAMIVIR;

EID: 84894443891     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12147     Document Type: Article

References (23)

1. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003-1032.
2. Hayden FG, Osterhaus AD, Treanor JJ et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337:874-880.
3. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-1024.
4. Whitley RJ, Hayden FG, Reisinger KS et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20:127-133.
5. Winther B, Block SL, Reisinger K, Dutkowski R. Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza. Int J Pediatr Otorhinolaryngol 2010; 74:684-688.
6. Lee EH, Wu C, Lee EU et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:1498-1504.
7. Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother 2010; 54:2575-2582.
8. Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y, Group MS. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 2010; 51:1167-1175.
9. Katsumi Y, Otabe O, Matsui F et al. Effect of a single inhalation of laninamivir octanoate in children with influenza. Pediatrics 2012; 129:e1431-e1436.
10. Shobugawa Y, Saito R, Sato I et al. Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan. J Infect Chemother 2012; 18:858-864.
11. Nakauchi M, Yasui Y, Miyoshi T et al. One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses. J Virol Methods 2011; 171:156-162.
12. WHO information for molecular diagnosis of influenza virus in humans - update. Available at http://www.who.int/influenza/resources/documents/molecular_diagnosis_influenza_virus_humans_update_201108.pdf (Accessed 6 August 2012).
13. Kawai N, Ikematsu H, Iwaki N et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2008; 56:51-57.
14. Kawai N, Ikematsu H, Iwaki N et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006; 43:439-444.
15. Kawai N, Ikematsu H, Iwaki N et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis 2005; 40:1309-1316.
16. Sugaya N, Mitamura K, Yamazaki M et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007; 44:197-202.
17. Sugaya N, Tamura D, Yamazaki M et al. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 2008; 47:339-345.
18. Ferraris O, Kessler N, Lina B. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res 2005; 68:43-48.
19. Ikematsu H, Kawai N, Kashiwagi S. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan. J Infect Chemother 2012; 18:529-533.
20. Sato M, Saito R, Sato I et al. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan. Tohoku J Exp Med 2008; 214:113-120.
21. Suzuki E, Ichihara K. The course of fever following influenza virus infection in children treated with oseltamivir. J Med Virol 2008; 80:1065-1071.
22. Munoz FM. Influenza virus infection in infancy and early childhood. Paediatr Respir Rev 2003; 4:99-104.
23. Suzuki E, Ichihara K, Johnson AM. Natural course of fever during influenza virus infection in children. Clin Pediatr (Phila) 2007; 46:76-79.